Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1252, 2000-01, pp. : 21-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Third-generation OCs: increased VTE risk supported by new analyses
Inpharma, Vol. 1, Iss. 1264, 2000-01 ,pp. :
Access to resources
Recommend
Oral estrogen linked with increased VTE risk
Reactions Weekly, Vol. 1, Iss. 1148, 2007-01 ,pp. :
Incidence of VT greater with third-, than with second-generation OCs
Inpharma, Vol. 1, Iss. 1298, 2001-01 ,pp. :
Drospirenone-containing OCs under review for VTE
Reactions Weekly, Vol. 1, Iss. 1355, 2011-01 ,pp. :